Skip to main content
logo
BioNote, Inc. (KRX:377740)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,835.00
-5.00 (-0.10%)
At close: Aug 21, 2026

BioNote Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-125,685-87,49855,261-20,497307,798676,601
Depreciation & Amortization
9,8919,2278,1868,2066,4514,106
Loss (Gain) From Sale of Assets
1,8111,671-20.25-265.2-13,412-361,225
Asset Writedown & Restructuring Costs
--4,8358,409--
Loss (Gain) From Sale of Investments
-11,098-1,907-9,3865,0005,150-15,047
Loss (Gain) on Equity Investments
201,193112,7184,98783,791-77,260-
Stock-Based Compensation
498.03264.899.92-1,6371,985
Provision & Write-off of Bad Debts
48.51901.3362.32-2,845-3,5966,827
Other Operating Activities
-31,354-17,992-12,749-82,440-4,08934,137
Change in Accounts Receivable
2,120-10,089-2,934855.5773,437220,048
Change in Inventory
-29.497,69710,632-436.63-33,543-9,826
Change in Accounts Payable
1,0341,622-982.63221.23-4,573-22,140
Change in Other Net Operating Assets
-2,874-2,234-74.32-4,193-8,9011,926
Operating Cash Flow
45,55514,38157,917-4,194249,100537,392
Operating Cash Flow Growth
25.50%-75.17%---53.65%123.98%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-3,945-8,111-10,462-3,963-42,266-51,425
Sale of Property, Plant & Equipment
7,5057,675727.1894.3649,399174.43
Cash Acquisitions
------6,266
Sale (Purchase) of Intangibles
-129.88-158.52-19.66-579.33-217.44-118.58
Investment in Securities
-69,849-77,416-72,415-477,108-37,446-133,747
Other Investing Activities
0000--
Investing Cash Flow
-66,418-78,011-82,170-481,555-30,530-191,383

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
---150,000--
Long-Term Debt Issued
---10.550-
Total Debt Issued
---150,01150-
Short-Term Debt Repaid
----150,000--
Long-Term Debt Repaid
--1,282-1,144-836-415.58-216.76
Total Debt Repaid
-1,409-1,282-1,144-150,836-415.58-216.76
Net Debt Issued (Repaid)
-1,409-1,282-1,144-825.5-365.58-216.76
Issuance of Common Stock
2,247--843.6673,280-
Repurchase of Common Stock
-5,000-5,001-3,108---
Dividends Paid
-22,972-20,272-20,411-49,919-49,959-49,959
Other Financing Activities
-----0-420
Financing Cash Flow
-27,134-26,555-24,663-49,90122,955-50,596

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
6,917714.298,8621,97820,930118.56
Net Cash Flow
-41,079-89,470-40,054-533,672262,455295,532

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
41,6106,27047,454-8,156206,834485,966
Free Cash Flow Growth
66.18%-86.79%---57.44%127.91%
Free Cash Flow Margin
32.92%5.30%46.17%-9.05%43.12%78.09%
Free Cash Flow Per Share
412.6861.95465.43-79.982193.655186.94
Levered Free Cash Flow
23,759-5,92214,076-18,697129,964399,410
Unlevered Free Cash Flow
23,884-5,74314,222-18,321130,017399,438

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
200.97287.11233.55602.8284.4444.25
Cash Income Tax Paid
3,97116,4065,00340,454157,006171,252
Change in Working Capital
249.62-3,0046,640-3,55326,420190,009